The influential advisory panel voted to no longer universally recommend the first dose of the hep B vaccine for newborns within 24 hours of birth.

Public health experts warn any delay to the newborn dose of the hepatitis B vaccine could threaten decades of progress.

A federal vaccine advisory committee this week is expected to discuss whether newborns should still get the hepatitis B vaccine — the first shot found to prevent cancer.